Deutsche Bank
LKFT

Deutsche Bank’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Deutsche Bank’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-375
Closed -$10.8K – 3649
2024
Q3 		$10.8K Buy
375
+3
+0.8% +$82 ﹤0.01% 3504
2024
Q2 		$9.22K Buy
372
+61
+20% +$1.73K ﹤0.01% 3465
2024
Q1 		$10K Sell
311
-3,784
-92% -$141K ﹤0.01% 3533
2023
Q4 		$166K Buy
+4,095
New +$151K ﹤0.01% 2973
2023
Q3 		– Sell
-294,207
Closed -$12M – 3749
2023
Q2 		$12M Hold
294,207
– – 0.01% 921
2023
Q1 		$11.4M Hold
294,207
– – 0.01% 930
2022
Q4 		$13.1M Hold
294,207
– – 0.01% 876
2022
Q3 		$12.5M Hold
294,207
– – 0.01% 886
2022
Q2 		$16.4M Hold
294,207
– – 0.01% 834
2022
Q1 		$18.2M Buy
+294,207
New +$18M 0.01% 862
2021
Q3 		– Sell
-1,040
Closed -$72K – 4504
2021
Q2 		$72K Sell
1,040
-6,575
-86% -$501K ﹤0.01% 4233
2021
Q1 		$587K Sell
7,615
-8,298
-52% -$764K ﹤0.01% 3003
2020
Q4 		$1.57M Buy
15,913
+9,636
+154% +$1.18M ﹤0.01% 2099
2020
Q3 		$891K Buy
6,277
+3,505
+126% +$584K ﹤0.01% 2273
2020
Q2 		$547K Buy
2,772
+867
+46% +$180K ﹤0.01% 2576
2020
Q1 		$373K Sell
1,905
-308
-14% -$66.3K ﹤0.01% 2625
2019
Q4 		$457K Sell
2,213
-15,644
-88% -$2.89M ﹤0.01% 2770
2019
Q3 		$2.73M Sell
17,857
-14,388
-45% -$2.36M ﹤0.01% 1733
2019
Q2 		$4.16M Sell
32,245
-10,696
-25% -$1.27M ﹤0.01% 1929
2019
Q1 		$5.05M Buy
42,941
+41,441
+2,763% +$4.18M ﹤0.01% 1867
2018
Q4 		$137K Sell
1,500
-16,699
-92% -$1.69M ﹤0.01% 4065
2018
Q3 		$2.05M Sell
18,199
-27,124
-60% -$2.87M ﹤0.01% 2840
2018
Q2 		$4.18M Sell
45,323
-37,827
-45% -$3.67M ﹤0.01% 2430
2018
Q1 		$8.29M Buy
83,150
+11,030
+15% +$1.19M ﹤0.01% 1780
2017
Q4 		$6.76M Sell
72,120
-6,502
-8% -$615K ﹤0.01% 1780
2017
Q3 		$8M Sell
78,622
-90,773
-54% -$7.93M 0.01% 1608
2017
Q2 		$13M Buy
169,395
+105,855
+167% +$8.9M 0.01% 1210
2017
Q1 		$5.47M Buy
63,540
+24,716
+64% +$1.78M ﹤0.01% 1624
2016
Q4 		$2.49M Sell
38,824
-28,116
-42% -$1.73M ﹤0.01% 2117
2016
Q3 		$4.33M Buy
66,940
+51,990
+348% +$2.93M ﹤0.01% 1832
2016
Q2 		$828K Buy
14,950
+1,300
+10% +$65.4K ﹤0.01% 3013
2016
Q1 		$570K Sell
13,650
-17,451
-56% -$810K ﹤0.01% 3130
2015
Q4 		$1.95M Buy
31,101
+21,101
+211% +$1.08M ﹤0.01% 2453
2015
Q3 		$407K Hold
10,000
– – ﹤0.01% 3472
2015
Q2 		$515K Buy
+10,000
New +$531K ﹤0.01% 3380

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deutsche Bank's LKFT Position: Q4 2024 in Review

Deutsche Bank sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 375 shares — an estimated $10.8K sold.

Deutsche Bank first reported a position in LKFT in Q2 2015 and held it in 35 quarters. The position peaked at $18.2M in Q1 2022. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.

  • Deutsche Bank reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Deutsche Bank sold 375 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $10.8K.
  • Deutsche Bank first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 35 quarters.
  • Deutsche Bank's Lakefront Biotherapeutics American Depositary Shares position peaked at $18.2M in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.

Based on Deutsche Bank's 13F filing for Q4 2024, filed 14 Feb 2025.